Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Meyer

Showing results (171-180 of 175) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 175 results.
Proceedings of the National Academy of Sciences of the United States of America|March 25, 2026
Immune cell profiling reveals expanded stem cell-like memory T cells in anti-GAD65-associated neurological syndromesSumanta Barman, Saskia Räuber, Katharina Eisenhut, et al.
Ebiomedicine|August 1, 2025
HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysisBrian C Zhang, Tilman Schneider-Hohendorf, Rebecca Elyanow, et al.
Journal of Neurology|February 27, 2024
5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2Katharina Vill, Moritz Tacke, Anna König, et al.
The Lancet Regional Health. Europe|February 16, 2024
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational studyRené Günther, Claudia Diana Wurster, Svenja Brakemeier, et al.
Brain : a Journal of Neurology|March 29, 2022
A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodiesChristine Strippel, Marisol Herrera-Rivero, Mareike Wendorff, et al.
Pageof 18

Showing results (171-180 of 175) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 175 results.
Proceedings of the National Academy of Sciences of the United States of America|March 25, 2026
Immune cell profiling reveals expanded stem cell-like memory T cells in anti-GAD65-associated neurological syndromesSumanta Barman, Saskia Räuber, Katharina Eisenhut, et al.
Ebiomedicine|August 1, 2025
HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysisBrian C Zhang, Tilman Schneider-Hohendorf, Rebecca Elyanow, et al.
Journal of Neurology|February 27, 2024
5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2Katharina Vill, Moritz Tacke, Anna König, et al.
The Lancet Regional Health. Europe|February 16, 2024
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational studyRené Günther, Claudia Diana Wurster, Svenja Brakemeier, et al.
Brain : a Journal of Neurology|March 29, 2022
A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodiesChristine Strippel, Marisol Herrera-Rivero, Mareike Wendorff, et al.
Pageof 18